Site-specific Tumor Grading System in Colorectal Cancer
- 1 February 2014
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 38 (2) , 197-204
Abstract
The study aimed to determine the value of a novel site-specific grading system based on quantifying poorly differentiated clusters (PDC; Grade(PDC)) in colorectal cancer (CRC). A multicenter pathologic review involving 12 institutions was performed on 3243 CRC cases (stage I, 583; II, 1331; III, 1329). Cancer clusters of ≥5 cancer cells and lacking a gland-like structure (PDCs) were counted under a ×20 objective lens in a field containing the maximum clusters. Tumors with <5, 5 to 9, and ≥10 PDCs were classified as grades G1, G2, and G3, respectively. According to Grade(PDC), 1594, 1005, and 644 tumors were classified as G1, G2, and G3 and had 5-year recurrence-free survival rates of 91.6%, 75.4%, and 59.6%, respectively (P<0.0001). Multivariate analysis showed that Grade exerted an influence on prognostic outcome independently of TNM staging; approximately 20% and 46% of stage I and II patients, respectively, were selected by Grade(PDC) as a population whose survival estimate was comparable to or even worse than that of stage III patients. Grade(PDC) surpassed TNM staging in the ability to stratify patients by recurrence-free survival (Akaike information criterion, 2915.6 vs. 2994.0) and had a higher prognostic value than American Joint Committee on Cancer (AJCC) grading (Grade(AJCC)) at all stages. Regarding judgment reproducibility of grading tumors, weighted κ among the 12 institutions was 0.40 for Grade(AJCC) and 0.52 for Grade(PDC). Grade(PDC) has a robust prognostic power and promises to be of sufficient clinical value to merit implementation as a site-specific grading system in CRC.Keywords
This publication has 54 references indexed in Scilit:
- Tumour budding is a strong and independent prognostic factor in pancreatic cancerEuropean Journal of Cancer, 2013
- Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional gradingVirchows Archiv, 2012
- Tumor budding is a significant indicator of a poor prognosis in lung squamous cell carcinoma patientsMolecular Medicine Reports, 2012
- Tumour budding: a promising parameter in colorectal cancerBritish Journal of Cancer, 2012
- Nomogram for Predicting the Benefit of Adjuvant Chemoradiotherapy for Resected Gallbladder CancerJournal of Clinical Oncology, 2011
- Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancerInternational Journal of Clinical Oncology, 2011
- Tumor budding and dedifferentiation in gallbladder carcinoma: potential for the prognostic factors in T2 lesionsVirchows Archiv, 2011
- Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinomaJournal of Oral Pathology & Medicine, 2011
- Tumor Budding as a Strong Prognostic Indicator in Invasive Ampullary AdenocarcinomasAmerican Journal of Surgical Pathology, 2010
- Tumor budding as a useful prognostic marker in esophageal squamous cell carcinomaDiseases of the Esophagus, 2004